Quick Results
Events

DRI's 29th Annual Drug and Medical Device Seminar

May 16 - 17, 2013
Share

Location:

Sheraton New York Times Square hotel
New York, New York

Date/Time:

May 16 - 17, 2013

DRI’s 29th annual Drug and Medical Device Seminar is the preeminent program for in-house and outside counsel who represent pharmaceutical and medical device manufacturers. We are pleased to feature a number of nationally recognized judges, attorneys (in-house and outside counsel), and other professionals who will address cutting-edge topics that are relevant to all who practice in this area, whether they are outside counsel, in-house attorneys, or others involved in the defense of pharmaceutical and medical device companies. This year’s program will offer a variety of presentations, including trial skills demonstrations, a panel discussion with a judge, a plaintiffs’ lawyer, and a defense lawyer involved in coordinated pharmaceutical proceedings in a unique venue, and litigation insights from leading defenders of drug and device cases. In addition to the outstanding program, there will be numerous networking opportunities, including our annual Young Lawyers Blockbuster and an exclusive in-house counsel only breakout.

What You Will Learn

  • How to use your advocacy skills to persuade the toughest audience
  • The latest on consolidated drug and device proceedings in Philadelphia
  • What jurors are thinking about the FDA
  • How to help a jury understand a state-of-the-art case
  • The latest on “judicial hellholes”
  • How to try a multiple-plaintiff pharmaceutical case
  • How to take the “junk” out of junk science

Events Contact

 
Ashley Siskey
T: 615.726.7301
  Email Professional

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Cancel Accept